CCL2 and non-Hodgkin lymphoma: Moreover, CCL2 is overexpressed by a variety of hematological malignancy (non-Hodgkin lymphomas) and solid tumors as colorectal, pancreatic, gastric, prostate, and breast cancer in particular [21].